CA
CVS icon

Calton & Associates’s CVS Health CVS Stock Holding History

Calton & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,570
Closed -$205K – 192
2024
Q1 		$205K Sell
2,570
-1,821
-41% -$139K 0.1% 180
2023
Q4 		$347K Buy
+4,391
New +$313K 0.14% 147
2023
Q3 		– Sell
-4,261
Closed -$295K – 137
2023
Q2 		$295K Buy
4,261
+925
+28% +$65.8K 0.14% 146
2023
Q1 		$248K Sell
3,336
-1,071
-24% -$89.8K 0.12% 178
2022
Q4 		$411K Buy
4,407
+1,411
+47% +$136K 0.16% 152
2022
Q3 		$285K Sell
2,996
-345
-10% -$34.1K 0.16% 143
2022
Q2 		$309K Sell
3,341
-1,034
-24% -$101K 0.17% 145
2022
Q1 		$442K Sell
4,375
-687
-14% -$72.2K 0.13% 186
2021
Q4 		$522K Sell
5,062
-2,078
-29% -$192K 0.14% 171
2021
Q3 		$605K Buy
7,140
+882
+14% +$73.9K 0.13% 176
2021
Q2 		$520K Sell
6,258
-147
-2% -$12K 0.1% 191
2021
Q1 		$482K Sell
6,405
-864
-12% -$62.9K 0.09% 186
2020
Q4 		$497K Buy
7,269
+402
+6% +$26.1K 0.09% 182
2020
Q3 		$401K Buy
6,867
+3,104
+82% +$193K 0.08% 186
2020
Q2 		$245K Buy
3,763
+316
+9% +$19.9K 0.05% 259
2020
Q1 		$205K Sell
3,447
-877
-20% -$58.5K 0.05% 267
2019
Q4 		$321K Sell
4,324
-86
-2% -$6.04K 0.06% 241
2019
Q3 		$278K Buy
4,410
+40
+0.9% +$2.37K 0.06% 259
2019
Q2 		$238K Buy
+4,370
New +$235K 0.07% 230
2019
Q1 		– Sell
-3,457
Closed -$227K – 265
2018
Q4 		$227K Buy
3,457
+387
+13% +$28.9K 0.08% 197
2018
Q3 		$242K Buy
+3,070
New +$219K 0.07% 236
2018
Q2 		– Sell
-5,244
Closed -$326K – 315
2018
Q1 		$326K Sell
5,244
-2,674
-34% -$192K 0.09% 218
2017
Q4 		$636K Buy
+7,918
New +$576K 0.16% 123

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Calton & Associates's CVS Position: Q2 2024 in Review

Calton & Associates sold out of CVS Health (CVS) in Q2 2024, closing a stake of 2,570 shares — an estimated $205K sold.

Calton & Associates first reported a position in CVS in Q4 2017 and held it in 23 quarters. The position peaked at $636K in Q4 2017. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Calton & Associates reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Calton & Associates sold 2,570 CVS Health shares in Q2 2024, an estimated $205K.
  • Calton & Associates first reported a position in CVS Health in Q4 2017 and held it in 23 quarters.
  • Calton & Associates's CVS Health position peaked at $636K in Q4 2017.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Calton & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.